Search results for ''

ASN Kidney Week

3-6 November 2022
Orlando, FL

ENYO Pharma was attending the world’s premier nephrology meeting of the American Society of Nephrology, ASN Kidney Week
https://www.asn-online.org/education/kidneyweek/

Read more »

Published on 25/11/2022

60th ERA congress, the Annual Nephrology Congress in Europe

15-18 June 2023
Milan, Italy

ENYO Pharma will attend and present at 60th ERA congress, the Annual Nephrology Congress in Europe
https://www.era-online.org/en/milan2023/

Read more »

Published on 17/11/2022

Multidisciplinary Day of Hepatology and Hepatic Transplantation

15 September, 2022
Lyon, France

ENYO Pharma sponsored and attent the Multidisciplinary Day of Hepatology and Hepatic Transplantation organized by Pr. Fabien Zoulim, Head of the Hepatology Department of the Hospices Civils de Lyon (HCL) the last September 15 at the Institute of Cognitive Sciences in Lyon, France. This annual seminar gathered around 150 professionals in hepatology.

Read more »

Published on 15/09/2022

HBV Forum 8 – Hepatitis B

21 June, 2022
London, UK

ENYO Pharma was attending HBV Forum 8 in London. The HBV Forum aims to advance the regulatory science for novel HBV therapeutic interventions and its associated morbidities in real time by providing an independent and neutral environment for ongoing multi-stakeholder dialogue.

https://forumresearch.org/hbv-forum/hbv-foruman-overview/

Read more »

Published on 05/08/2022

AASLD-EASL HBV Endpoints 2022

3-4 June, 2022
Washington, US

ENYO Pharma was attending AASLD-EASL HBV Endpoints 2022 to share news on therapeutic endpoints, trial designs and safety concerns with regards to novel therapeutic approaches for treatment of chronic hepatitis B and D. It was a great opportunity to meet academic, regulatory, pharmaceutical communities and patients in liver disease area.

https://easl.eu/event/aasld-easl-endpoints-2022/

Read more »

Published on 05/08/2022